Synchronous metastases from colorectal cancer. Treatment and long-term survival compared to patients with metachronous metastases: a population-based study from Central Norway 2001–2015
A key determinant of better survival for patients with metachronous CRC metastases compared to synchronous was a significantly higher proportion treated with curative intent. Survival for both patients with synchronous and metachronous metastases taken collectively steadily improved during the study period, driven by the increased proportions and improved survival for the subsets with curative intent treatment.
Authors
- Rachel Genne Dille-Amdam (ORCID: https://orcid.org/0009-0001-4772-3236)
- Jon Erik Grønbech (ORCID: https://orcid.org/0000-0002-6034-867X)
- Erling A. Bringeland (ORCID: https://orcid.org/0000-0002-1989-0029)
- Per Even Storli (ORCID: https://orcid.org/0000-0002-5072-4248)
- Tor Åge Myklebust (ORCID: https://orcid.org/0000-0003-4645-1635)
- Mads Vikhammer Gran (ORCID: https://orcid.org/0000-0003-4771-7546)
- Gaute Havik Skjerseth
Institutions
- Norwegian Institute of Public Health (NO)
- Norwegian University of Science and Technology (NO)
- Ålesund Hospital (NO)
- St Olav's University Hospital (NO)
- Cancer Registry of Norway (NO)
Publication Details
- Journal
- Acta Oncologica
- Published
- 2025-06-18
- DOI
- https://doi.org/10.2340/1651-226x.2025.42985
- Citations
- 5
- Primary Topic
- Colorectal Cancer Treatments and Studies
- Type
- article
- Field-Weighted Citation Impact
- 5.23